Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 2224 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Ranbaxy recalls Nitrofurantoin capsules

Ranbaxy Pharmaceuticals, a wholly owned subsidiary of Ranbaxy Laboratories, has reported that it is conducting a voluntary recall of all lots of Nitrofurantoin capsules, USP 100mg currently on

Allergan Q1 net earnings decrease to $45m

Allergan, a multi-specialty healthcare company, has reported net earnings of $45m for the first quarter of 2009, compared to $107.9m for the first quarter of 2008. Allergan has

Teva Q1 net income surges

Net sales for the first quarter increased 22% to $3.15 billion, compared to $2.57 billion in the first quarter of 2008. The acquisition of Barr contributed to the